SQD Share Price

Open 0.16 Change Price %
High 0.16 1 Day 0.00 0.00
Low 0.16 1 Week 0.00 0.00
Close 0.16 1 Month -0.02 -11.11
Volume 21500 1 Year -0.20 -55.56
52 Week High 0.45
52 Week Low 0.15
SQD Important Levels
Resistance 2 0.16
Resistance 1 0.16
Pivot 0.16
Support 1 0.16
Support 2 0.16
CVE Canada Most Active Stocks
MOO 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
More..
CVE Canada Top Gainers Stocks
QZM 0.08 100.00%
BVQ 0.02 100.00%
DDX 0.50 100.00%
SRG 0.24 100.00%
SRG 0.24 100.00%
SRG 0.24 100.00%
AZU 0.02 100.00%
AZU 0.02 100.00%
RDM 0.21 90.91%
RDM 0.21 90.91%
More..
CVE Canada Top Losers Stocks
EAS 0.00 -100.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
PTR 0.02 -33.33%
More..

SQI Diagnostics Inc (CVE: SQD)

SQD Technical Analysis 5
As on 16th Jan 2017 SQD Share Price closed @ 0.16 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.28 & Strong Sell for SHORT-TERM with Stoploss of 0.18 we also expect STOCK to react on Following IMPORTANT LEVELS.
SQD Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
SQD Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.sqidiagnostics.com
SQD Address
SQD
36 Meteor Drive
Toronto, ON M9W 1A4
Canada
Phone: 416-674-9500
Fax: 416-674-9300
SQD Latest News
In Brief This Week: New York Genome Center, Omicia, NanoString   GenomeWeb   - 14th Jan 17
U.S. In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune ...   Yahoo Finance   - 10th Jan 17
SQI Diagnostics Inc (TSXV:SQD): How Well Does It Fare Against This Financial ...   Simply Wall St   - 16th Dec 16
BRIEF-SQI Diagnostics Q4 loss per share $0.03   Reuters   - 07th Dec 16
SQI Diagnostics Inc. Announces Closing of Rights Offering   Canada NewsWire (press release)   - 19th Aug 16
Autoimmune Disease Diagnostics Market size worth USD 15 Billion by 2023 ...   GlobeNewswire (press release)   - 13th Jul 16
World Market for Microarrays 2015-2020 - Research and Markets   Business Wire (press release)   - 22nd Feb 16
Research and Markets: Leading 100 Medical Technology Companies of USA/Canada 2015   Business Wire (press release)   - 23rd Mar 15
New Celiac Disease Panel Offers Promising, New Diagnostic Tools To Aid Doctors ...   IBD News Today   - 10th Nov 14
Microarray Markets   PR Newswire (press release)   - 19th Feb 14
Interactive Technical Analysis Chart SQI Diagnostics Inc ( SQD CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on SQI Diagnostics Inc
SQD Business Profile
SQI Diagnostics Inc., a life sciences and diagnostics company, develops and commercializes proprietary technologies and products for advanced microarray diagnostics. It offers diagnostic tools and services, including test design, development, and validation services resulting in custom multiplex tests; and multiplexed IVD products targeting protein and antibody biomarkers in autoimmune and other immunology markets. The company provides sqidworks diagnostic platform, a fully-automated microarray processing and analytical instrument that provides cost savings and other benefits over existing technologies; sqidlite Bench-Top diagnostic system, which offers laboratories with workflow solutions from dilutions through reporting to run protein and antibody multiplexed immunoassays; sqid-X system, a semi-automated bench top platform that incorporates SQI’s technology with the exception of automated fluidics handling; and Ig_plex microarrays and custom Ig_plex tests to accurately measure multiple biomarkers in a single test. It serves clinical, academic, diagnostic, and pharmaceutical laboratories; and contract research organizations. The company is headquartered in Toronto, Canada.